{"title":"Experimental Rat and Mouse Carotid Artery Surgery: Injury & Remodeling Studies.","authors":"Andrew W Holt, David A Tulis","doi":"10.1155/2013/167407","DOIUrl":"https://doi.org/10.1155/2013/167407","url":null,"abstract":"<p><p>In cardiovascular research, translation of benchtop findings to the whole body environment is often critical in order to gain a more thorough and comprehensive clinical evaluation of the data with direct extrapolation to the human condition. In particular, developmental and/or pathophysiologic vascular growth studies often employ in vitro approaches such as cultured cells or tissue explant models in order to analyze specific cellular, molecular, genetic and/or biochemical signaling factors under pristine controlled conditions. However, validation of in vitro data in a whole body setting complete with neural, endocrine and other systemic contributions provides essential proof-of-concept from a clinical perspective. Several well-characterized experimental in vivo models exist that provide excellent proof-of-concept tools with which to examine vascular growth and remodeling in the whole body. This article will examine the rat carotid artery balloon injury model, the mouse carotid artery wire denudation injury model, and rat and mouse carotid artery ligation models with particular emphasis on minimally invasive surgical access to the site of intervention. Discussion will include key scientific and technical details as well as caveats, limitations, and considerations for practical use for each of these valuable experimental models.</p>","PeriodicalId":89784,"journal":{"name":"ISRN minimally invasive surgery","volume":"2013 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2013-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/167407","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31503195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lauren L Levy, Peter M Vila, Richard W Park, Richard Schwarz, Alexandros D Polydorides, Marita S Teng, Vivek V Gurudutt, Eric M Genden, Brett Miles, Sharmila Anandasabapathy, Ann M Gillenwater, Rebecca Richards-Kortum, Andrew G Sikora
{"title":"High-Resolution Optical Imaging of Benign and Malignant Mucosa in the Upper Aerodigestive Tract: An Atlas for Image-Guided Surgery.","authors":"Lauren L Levy, Peter M Vila, Richard W Park, Richard Schwarz, Alexandros D Polydorides, Marita S Teng, Vivek V Gurudutt, Eric M Genden, Brett Miles, Sharmila Anandasabapathy, Ann M Gillenwater, Rebecca Richards-Kortum, Andrew G Sikora","doi":"10.5402/2012/364285","DOIUrl":"https://doi.org/10.5402/2012/364285","url":null,"abstract":"<p><strong>Background: </strong>High-resolution optical imaging provides real-time visualization of mucosa in the upper aerodigestive tract (UADT) which allows non-invasive discrimination of benign and neoplastic epithelium. The high-resolution microendoscope (HRME) utilizes a fiberoptic probe in conjunction with a tissue contrast agent to display nuclei and cellular architecture. This technology has broad potential applications to intraoperative margin detection and early cancer detection.</p><p><strong>Methods: </strong>Our group has created an extensive image collection of both neoplastic and normal epithelium of the UADT. Here, we present and describe imaging characteristics of benign, dysplastic, and malignant mucosa in the oral cavity, oropharynx, larynx, and esophagus.</p><p><strong>Results: </strong>There are differences in the nuclear organization and overall tissue architecture of benign and malignant mucosa which correlate with histopathologic diagnosis. Different anatomic subsites also display unique imaging characteristics.</p><p><strong>Conclusion: </strong>HRME allows discrimination between benign and neoplastic mucosa, and familiarity with the characteristics of each subsite facilitates correct diagnosis.</p>","PeriodicalId":89784,"journal":{"name":"ISRN minimally invasive surgery","volume":"2012 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/364285","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31404394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hyun J Bang, Peter J Littrup, Brandt P Currier, Dylan J Goodrich, Minsig Choi, Lance K Heilbrun, Allen C Goodman
{"title":"Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations.","authors":"Hyun J Bang, Peter J Littrup, Brandt P Currier, Dylan J Goodrich, Minsig Choi, Lance K Heilbrun, Allen C Goodman","doi":"10.5402/2012/942364","DOIUrl":"https://doi.org/10.5402/2012/942364","url":null,"abstract":"<p><strong>Purpose: </strong>To assess feasibility, complications, local tumor recurrences, overall survival (OS) and estimates of cost-effectiveness for multi-site cryoablation (MCA) of oligo-metastatic colorectal cancer (mCRC) in a prospective study.</p><p><strong>Materials and methods: </strong>111 CT and/or US-guided percutaneous MCA procedures were performed on 151 tumors in 59 oligo mCRC patients. Mean patient age was 63 years (range 21-92 years), consisting of 29 males and 30 females. Tumor location was grouped according to common metastatic sites. Median OS was determined using the Kaplan-Meier. Estimates of MCA costs per LYG were compared to historical values for systemic therapies.</p><p><strong>Results: </strong>A mean 1.9 MCAs per patient were performed with a median clinical follow-up of 12 months. Major complication and local recurrence rates were 8% (9/111) and 12% (18/151), respectively. Median overall-survival (OS) was 23.6 months with an estimated 3-year survival rate of ~30%. Cryoablation remained cost effective with or without the presence of systemic therapies, with an adjunctive cost-effectiveness ratio (ACER) of $39,661-$85,580 per LYG.</p><p><strong>Conclusions: </strong>Multi-site cryoablation had very low complication and local recurrence rates, and was able to provide local control even for diverse soft tissue locations. Even as an adjunct to systemic therapies, MCA appeared cost-effective, with apparent increased survival.</p>","PeriodicalId":89784,"journal":{"name":"ISRN minimally invasive surgery","volume":"2012 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33332869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}